This video is a poster presentation contributing to our Virtual Cancer Conference 2020 and focuses on the effect of the hypersialylated Multiple Myeloma cell surface on NK cell-mediated immunosurveillance.
Related and Helpful Resources
Virtual Cancer Conference: CRISPR in Cancer Research: https://www.synthego.com/events/crispr-cancer-webinar-05-20-2020
CRISPR Cancer Research: https://www.synthego.com/crispr-cancer
CAR T Therapy: Treating Cancer with Engineered Cells: https://www.synthego.com/blog/car-t-cancer-therapies
Learn More About Synthego: https://www.synthego.com
Subscribe Now to The Bench Blog: https://www.synthego.com/blog
Schedule a Free CRISPR Assessment: https://www.synthego.com/discovery
SYNTHEGO ON SOCIAL
Tweets by Synthego
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s full-stack platform vertically integrates proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance both basic research and therapeutic development programs.
By providing both commercial and academic researchers and therapeutic developers with unprecedented access to cutting-edge genome engineering, Synthego is at the forefront of innovation, accelerating the development of truly engineered biology.